Click on the links below to view the related documents in pdf, please be patient while the pdf documents open.

SASCRO Statement on Appropriate Clinical Indications for Intensity Modulated Radiation Therapy (IMRT) or Volumetric Modulated Arc Radiotherapy (VMAT) as part of Universal Health Care Coverage in South Africa

    • About:IMRT is considered a standard of care in the treatment of many types cancer in South Africa. It is widely available, and used regularly, in many radiation departments– be they in the private or public sector.
    • Download:SASCRO Statement on IMRT or VMAT

Trans Oral Robotic Surgery (TORS) and Chemo-Radiation

    • About:A series of two-page advertisements have appeared in the September and November 2016 issues of the SAMJ, entitled ‘da Vinci Transoral Robotic Surgery (TORS) is a minimally invasive alternative to open surgery and full-dose chemoradiation therapy for diseases of the head and neck’. As these advertisements go beyond simply marketing surgical equipment, but seek to influence patients, referring doctors, oncologists and head and neck surgeons on how to treat cancers of the head and neck and sleep apnoea, we have taken the unusual step of writing to the editor.
    • Download:TORS letter - Joseph SAMJ Jan 2017
    • Download:TORS letter - Fagan et al SAMJ Jan 2017

SASCRO Statement on Photodynamic Therapy

SASCRO Endorsed Audit Guidelines for Oncology Departments

    • About:This baseline checklist is for use as part of a continuous improvement program. ICON will be available to assist with this program. It is based on the National Core Standards of the Dept. of Health with additional Oncology measures.
    • Download:SASCRO Endorsed Audit Guidelines for Oncology Departments

SASCRO Guidelines for CPD Accreditation of Meetings

    • About:The primary purpose of CPD activities is to address the educational needs of medical doctors and other health care providers in order to improve and maintain the health care of patients.
    • Download:SASCRO Guidelines for CPD Accreditation of Meetings

SASCRO Statement on Itinerant Practice as it Relates to Prostate Seed Implants

    • About:SASCRO takes it's guidance from the HPCSA's General Ethical Rule 6 (as published under Government Notice R717 in Government Gazette 29079 of 4 August 2006, and as amended by subsequent Government Notices) "[a] practitioner may conduct a regularly recurring itinerant practice at a place where another practitioner is established if, in such itinerant practice, such practitioner renders the same level of service to patients, at the same fee as the service which he or she would render in the area in which he or she is conducting a resident practice.
    • Link:SASCRO Statement on Itinerant Practice as it Relates to Prostate Seed Implants

Radiation Fee Rules

Chemo Fee Rules

    • About:Code descriptions, interpretation and guidelines for use by medical oncologists (PR 23*), clinical and radiation oncologists (PR 40*), pediatric oncologists and clinical hematologists (PR 27*).
    • Download:Chemo Fee Rules

SASCRO Endorsement of Meetings

    • About:SASCRO offers endorsements of academic meetings and allows the use of the SASCRO logo provided that the SASCRO has a representative as part of the planning committee for the meeting.
    • Download:SASCRO Endorsement of Meetings

SASCRO Statement on Unsealed Radio-Active Isotopes

    • About:Unsealed radio-active isotopes may be used to treat selected patients with cancer, for example, patients with cancer of the thyroid, prostate and neuro-endocrine tumours. With reference to their training, education and scopes of practice and the law, only Radiation Oncologists and Nuclear Physicians may administer unsealed radio-active isotopes to patients.
    • Download:SASCRO Statement on Unsealed Radio-Active Isotopes

SASCRO Statement on IORT

    • About:The aim of lumpectomy and post-operative irradiation for selected patient with early breast cancer is preservation of the breast while ensuring no increase in the local recurrence rate compared with total mastectomy.
    • Download:SASCRO Statement on IORT

SASCRO Statement on Prostate Radioactive Ligand Therapy

Website Sponsored by: